ESPERITE ESP financial results for 2017 are published.
  Amsterdam The Netherlands 23 November 2018 ESPERITE N.V. Euronext ESP "Esperite" "the Company" or "the Group" has published today its Annual...
View ArticleOncobiologics Inc ONS Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryOncobiologics Inc Oncobiologics is a clinical stage biopharmaceutical company that identifies develops manufactures and commercializes biosimilar therapeutics in the areas of immunology and...
View ArticleTheravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD1473...
DUBLIN Nov. 20 2018 PRNewswire Theravance Biopharma Inc. NASDAQ TBPH "Theravance Biopharma" or the "Company" today announced dosing of the first patient in a Phase 2...
View ArticleAnaeropharma CoOpts Microbe For Targeted Fight Against Hypoxic Tumors
Japanese venture Anaeropharma Science is working on a unique approach to targeted drug delivery it says confers advantages including fewer...&160;&160;&160;
View ArticleMorphoSys Announces Approval of TremfyaR Guselkumab in Japan for the...
DGAPNews MorphoSys AG Key words Regulatory Approval26.11.2018 0730 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany November 26 2018MorphoSys Announces...
View ArticleYear in Review Crohn's Disease
MedPage Today Newer treatments make inroads but risks and obstacles remain
View ArticleuBiome Appoints Dr. Brandon Wuerth MD Founder of IBDwatch to its Medical...
The leader in microbial genomics appoints Gastroenterology Fellow to its board of medical advisors.SAN FRANCISCO PRWEB November 26 2018 uBiome the leader in microbial genomics announces the addition of...
View ArticleIB Pharmaceuticals Inc INNT Pharmaceuticals Healthcare Deals and Alliances...
SummaryIB Pharmaceuticals Inc IB Pharmaceuticals formerly Innovate Biopharmaceuticals Inc is a clinicalstage biotechnology company that discovers and develops novel medicines for orphan and...
View ArticleuBiome Appoints Dr. Steven Salzberg PhD Computational Biology and Genomics...
The leader in microbial genomics appoints John Hopkins University researcher to its board of scientific advisors.SAN FRANCISCO PRWEB November 27 2018 uBiome the leader in microbial genomics announces...
View ArticleMeet LillyPad's Dr. Kiley an industry trailblazer who's helping transform the...
Meet LillyPad's Dr. Kiley an industry trailblazer who's helping transform the neurodegeneration field. Since 2009 her team has targeted highprofile conditions like Parkinson's Alzheimer's &...
View ArticleuBiome Awards Grant to MEBO Research a Public Charity to Study the Dynamic of...
The leader in microbial genomics awards microbiome test kits and study support to 501c3 public charity and patient advocacy campaign to identify microbial communities associated with flareups and...
View ArticleTiziana Announces Initiation of Phase 1 Clinical Trial with Nasal...
A breakthrough approach for treatment of neurodegenerative diseases such as progressive multiple sclerosis Tiziana Life Sciences plc Tiziana or the Company Nasdaq TLSA AIM TILS a UK biotechnology...
View ArticleEsperite ESP with The Cell Factory prepares to raise series A round of...
This investments would put the Company at the pole position on the market with its four Extracellular Vesicles drug candidates for Crohn's Bronchopulmonary dysplasia Epilepsy and Stroke...
View ArticleVIDEO BioNTech CBO Outlines Infectious Disease Ambitions
German mRNAfocused biotech BioNTech is branching out from its immunooncology focus to explore the potential of its platforms in infectious...&160;&160;
View ArticleKOL Perspectives Perception of mirikizumab in moderatetosevere UC Report...
KOL Perspectives Perception of mirikizumab in moderatetosevere UCSummaryThis KOL Insight briefing focuses on KOLs views of mirikizumab in moderatetosevere UC.Questions topics Perception of Phase II...
View ArticleKOL Perspectives Patient Niches in IBD Report Updated 11092018 Prices from...
KOL Perspectives Patient Niches in IBDSummaryThis KOL Insight briefing focuses on KOLs views of Patient Niches in IBD.Questions topics Perceptions on patient niches and treatments of fistulizing...
View ArticleKOL Perspectives Histologic Healing in Crohn's disease Report Updated...
KOL Perspectives Histologic Healing in Crohn's diseaseSummaryThis KOL Insight briefing focuses on KOLs views of Histologic Healing in Crohn's disease.Questions topics Use of histological assessment in...
View ArticleKOL Perspectives Adaptive Trial Designs in IBD Report Updated 22082018 Prices...
KOL Perspectives Adaptive Trial Designs in IBDSummaryThis KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.Questions topics Current challenges in IBD clinical trials Adaptive...
View ArticleuBiome Appoints Dr. Wendy Garrett MD PhD Gastrointestinal Immunologist and...
The leader in microbial genomics appoints Harvard Immunologist to its board of medical advisors.SAN FRANCISCO PRWEB November 29 2018 uBiome the leader in microbial genomics announces the addition of...
View ArticleuBiome Appoints Dr. Hannah Holscher PhD RD Director of the Nutrition & Human...
The leader in microbial genomics appoints clinical nutritionist and gut microbiome researcher to its board of scientific advisors.SAN FRANCISCO PRWEB November 30 2018 uBiome the leader in microbial...
View Article